Fukui H, Zhang X, Sun C, Hara K, Kikuchi S, Yamasaki T, Kondo T, Tomita T, Oshima T, Watari J, Imura J, Fujimori T, Sasako M, Miwa H
Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.
1] Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Japan [2] Department of Geriatric Digestive Internal Medicine, Sichuan Academy of Medical Science & Sichuan People's Hospital, Chengdu 610072, China.
Br J Cancer. 2014 Aug 12;111(4):763-71. doi: 10.1038/bjc.2014.336. Epub 2014 Jun 17.
Interleukin-22 (IL-22) has been recently highlighted owing to its biological significance in the modulation of tissue responses during inflammation. However, the role of IL-22 in carcinogenesis has remained unclear. Here, we investigated the pathophysiological significance of IL-22 expression in gastric cancer tissues and examined the mechanism by which IL-22 promotes gastric cancer cell invasion.
Human gastric cancer specimens were analysed by immunohistochemistry for expression of IL-22 and IL-22 receptor 1 (IL-22R1). The effects of IL-22-induced STAT3 and ERK signalling on invasive ability of gastric cancer cells were examined using a small-interfering RNA system and specific inhibitors. AGS cells were co-cultured with cancer-associated fibroblasts (CAFs) from human gastric cancer tissues and assessed by invasion assay.
Interleukin-22 and its receptor were expressed in α-smooth muscle actin-positive stromal cells and tumour cells at the invasive front of gastric cancer tissues, respectively. The expression of IL-22 and IL-22R1 was significantly related to lymphatic invasion. Interleukin-22 treatment promoted the invasive ability of gastric cancer cells through STAT3 and ERK activation. The invasive ability of gastric cancer cells was significantly enhanced by co-culture with IL-22-expressing CAFs.
Interleukin-22 produced by CAFs promotes gastric cancer cell invasion via STAT3 and ERK signalling.
白细胞介素-22(IL-22)因其在炎症过程中调节组织反应的生物学意义而受到关注。然而,IL-22在致癌作用中的角色仍不明确。在此,我们研究了IL-22在胃癌组织中表达的病理生理意义,并探讨了IL-22促进胃癌细胞侵袭的机制。
采用免疫组织化学方法分析人胃癌标本中IL-22和IL-22受体1(IL-22R1)的表达。利用小干扰RNA系统和特异性抑制剂检测IL-22诱导的信号转导及转录激活因子3(STAT3)和细胞外调节蛋白激酶(ERK)信号对胃癌细胞侵袭能力的影响。将AGS细胞与人胃癌组织来源的癌相关成纤维细胞(CAFs)共培养,并通过侵袭实验进行评估。
IL-22及其受体分别在胃癌组织侵袭前沿的α平滑肌肌动蛋白阳性基质细胞和肿瘤细胞中表达。IL-22和IL-22R1的表达与淋巴侵袭显著相关。IL-22处理通过激活STAT3和ERK促进胃癌细胞的侵袭能力。与表达IL-22的CAFs共培养可显著增强胃癌细胞的侵袭能力。
CAFs产生的IL-22通过STAT3和ERK信号通路促进胃癌细胞侵袭。